Our multi‐omics analysis revealed that EGFR overexpression in GBM is interconnectivity regulated by mutations, methylation, and CNV, highlighting the potential of combination therapy targeting the aberrant rewiring signalling pathways. This evidence concerns the gene EGFR and glioblastoma.